Milano, Impact Hub, Via Aosta 4

Red biotech

More info pietro.pierangeli@argonhealthcare.com; chiara.tettamanti@argonhealthcare.com

The conference aims to present the italian situation in the field of biotechnological research for health, evaluating opportunities and risks. At theme that will be explored is the use of artificial intelligence applied to this field

Program:

  • 30 Registration
  • 00 Introduction –  M. Vergnano, Argon Healthcare; G. Recchia, Fondazione Smith Kline
  • 15:10 Biotechnology in Italy: Lights and Shapes – L. Vingiani, Assobiotec – Federchimica
  • 30 Pharma2020, years of convergence – G. Recchia, Fondazione Smith Kline
  • 50 Advanced Therapy in third year. Where are we? Where are we going? -C. Bovolenta, Molmed
  • 16:10 Startup, Technology Transfer and Biotechnology: what obstacles should we overcome? – F. Bianco, Bio4Dreams
  • 16:30 Artificial intelligence for Research and Assistance: where are we now? – M. Matteucci, Milan Politecnico
  • 16:50 Patient and citizen expectations of Artificial Intelligence applied to health – ML Mottes, Onlus Milan Diabetic Association
  • 17:10 What opportunities from Biotechnology and Artificial Intelligence?

Round Table

Moderator M. Vergnano, Argon

  1. Matteucci, G.Recchia, F Bianco, C Bovolenta, ML Mottes and the public
  • 18:00 Conclusions – G. Recchia; M.Vergnano

Notes:

  • The conference proceedings will be published in “Nuove tendenze”, SmithKline Foundation’s magazine
  • The conference will be broadcasted live streaming
  • The audience on site and remotely can ask questions through “Pigeonhole”

 

Organiser: Argon Healthcare; Fondazione Smith Kline